July 25, 2013 | In 2010, GlaxoSmithKline, the Genomics Institute of the Novartis Research Foundation and St Jude Children's Research Hospital in Memphis, Tenn., publicly released over 20,000 compounds active against malaria, launching open source research into the disease. The Medicines for Malaria Venture reports on their progress since. Guardian